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Abstract
Purpose: Sigma-1 receptor ligands modulate the release of several neurotransmitters and
intracellular calcium signaling. We examined the binding of a radiolabeled sigma-1 agonist in the
aging rat brain with positron emission tomography (PET).
Procedures: Time-dependent uptake of [11C]SA4503 was measured in the brain of young (1.5 to
3 months) and aged (18 to 32 months) Wistar Hannover rats, and tracer-kinetic models were
fitted to this data, using metabolite-corrected plasma radioactivity as input function.
Results: In aged animals, the injected probe was less rapidly metabolized and cleared. Logan
graphical analysis and a 2-tissue compartment model (2-TCM) fit indicated changes of total
distribution volume (VT) and binding potential (BPND) of the tracer. BPND was reduced particularly
in the (hypo)thalamus, pons, and medulla.
Conclusions: Some areas showed reductions of ligand binding with aging whereas binding in
other areas (cortex) was not significantly affected.
Key Words: Senescence, Sigma-1 receptor, Agonist binding, Positron emission tomography,
Kinetic modeling, Brainstem, Hypothalamus
Introduction
Sigma-1 receptors are widely distributed throughout the
brain and are expressed mainly on neurons, with the highest
expression levels in various cranial nerve nuclei in the
midbrain, pons, and medulla [1–4]. These receptors are
ligand-regulated molecular chaperones in the endoplasmatic
reticulum and play a modulatory role in intracellular calcium
signaling [5]. Activated sigma-1 receptors translocate from
the endoplasmatic reticulum to the plasma membrane and
modulate the activity of ion channels and neurotransmitter
release [5]. Sigma-1 receptor stimulation can increase the
extracellular concentrations of dopamine [6–8], acetylcho-
line [9, 10], and glutamate [11–13]. Sigma-1 receptors have
been implied in cellular differentiation [14], neuritogenesis
[15], neuroprotection, and cognition [16].
Aging has a strong impact on neurotransmission in the
mammalian brain. Particularly, the dopaminergic system has
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been widely examined, not only with in vitro techniques but
also with in vivo imaging. Substantial losses of dopamine D1
and D2 receptors binding with increasing age have been
observed in micro-positron emission tomography (microPET)
studies of young (2 to 6 months) and old (18 to 24 months) rats
[17, 18]. Cholinergic deficits have also been detected in this
animal species, using microPET and the presynaptic choliner-
gic marker [18F]fluoroethoxybenzovesamicol. [19]
In contrast to the extensive data on dopaminergic and
cholinergic neurotransmission, sigma-1 receptors in the
aging rodent brain have been little examined. Imaging
studies in rats have not yet been reported, and published
data from in vitro assays concerned either the whole brain
[20–23] or only a single brain region, i.e., the striatum [24].
Moreover, most of these data were acquired with sigma
ligands which lacked subtype-selectivity [20, 21, 24]. For
this reason, we performed quantitative microPET studies
with a subtype-selective radioligand in living rats of
different ages and determined sigma-1 receptor binding
potentials throughout the brain. We were interested in
answering the question whether sigma-1 receptor popula-
tions in various brain regions are differently affected by
healthy aging and whether observed changes (if any) could
be related to changes of rodent physiology at advancing age.
Materials and Methods
Radioligand
The l i g a n d 1 - [ 2 - ( 3 , 4 - d im e t h o x yph e n e t h y l ) ] - 4 - ( 3 -
phenylpropyl)piperazine ([11C]SA4503) was prepared by reaction
of [11C]methyl iodide with 4-O-demethyl SA4503, according to a
published method [25]. The decay-corrected radiochemical yield
was ~24 %, the specific radioactivity was 9100 TBq/mmol at the
moment of injection, and radiochemical purity was 998 %. The
[11C]SA4503 solution had a pH of 6.0 to 7.0.
Animals
Male Wistar Hannover rats were obtained from Harlan
(The Netherlands) and Semmelweis University Budapest. Animals
from the following age groups were included: 1.5 (n=9), 3 (n=10),
18 (n=5), 24 (n=4), and 32 (n=5) months. About 40 % of the rats
aged 18 to 32 months originally intended for this study were found
to have pituitary tumors which affected tracer kinetics in the brain
[26]. The microPET data of these animals were thus not included in
the current manuscript. Since any differences between the 1.5 and
3 month groups, or the 18, 24, and 32 month groups were small and
in most cases not statistically significant, we decided to pool data
for young (1.5 to 3 months) and aged (18 to 32 months) rats in the
following Results and Discussion sections.
The rats were housed in Makrolon cages on a layer of wood
shavings at 21±2 °C and a fixed 12-h light–dark regime (lights on
at 7:00 a.m.). Food (standard laboratory chow, RMH-B, Hope
Farms, The Netherlands) and water were available ad libitum. After
arrival, the rats were allowed to acclimatize for at least seven days.
The study protocol was approved by the Institutional Animal Care
and Use Committee of the University of Groningen. All experi-
ments were performed by licensed investigators in compliance with
the law on animal experiments of The Netherlands. Important data
concerning the animals (purpose of use, body and brain weights,
injected tracer dose, and mass) are provided in Table 1.
Arterial Blood Sampling
Before microPET scanning, rats were anesthetized with isoflurane
in medical air (5 % for induction and 2 % for maintenance). An
incision was made parallel to the femoral artery. The femoral artery
was separated from the femoral vein and temporarily ligated to
prevent leakage of blood. A small incision was made in the artery,
and a cannula was inserted (0.8-mm outer, 0.4-mm inner diameter).
The cannula was secured to the artery with a suture and attached to
a syringe filled with heparinized saline.
From each rat, fifteen arterial blood samples (volume 0.1 to 0.15 ml)
were drawn at 0.25, 0.5, 0.75, 1, 1.25, 1.5, 2.0, 3, 5, 7.5, 10, 15, 30, 60,
and 90 min after [11C]SA4503 injection. Plasma was obtained from
these blood samples by centrifugation (5 min in Eppendorf-type
centrifuge at 13,000×g). Radioactivity in plasma samples (25 μl) was
determined using a calibrated gamma counter (CompuGammaCS 1282,
LKB-Wallac, Turku, Finland)
In separate groups of rats, larger volumes of blood ranging from
0.4 to 1.6 ml were collected at 5, 10, 20, 40, and 60 min, and a
metabolite analysis was performed using a published method [27].
Briefly, plasma was obtained by centrifugation (2 min in
Eppendorf-type centrifuge at 13,000×g) and de-proteinized using
one third the volume of 20 % trichloroacetic acid in
acetonitrile. The mixture was centrifuged for 2 min at 13,000×g,
and the supernatant was injected in a reversed-phase HPLC system
to separate the parent tracer from its metabolites (μBondapak C18
Table 1. Animal data
Young (1.5 to 3 months) Aged (18 to 32 months)
Scanned with rapid arterial blood sampling (n) 12 10
Metabolite analysis (n) 7 8 (4 were also scanned)
Brain TACs used for kinetic analysis (n) 12 14
Body weight (g) 215±3 (1.5 months, n=9) 605±28
308±8 (3 months, n=10)
Brain weight (g) 1.73±0.03 (1.5 months) 2.15±0.08
1.90±0.04 (3 months)
Injected tracer dose (MBq) 14.7±2.8 26.8±6.2
Injected mass (nmol, max.) 0.15±0.03 0.27±0.06
Injected mass (pmol/g, max.) 5.7±1.1 4.5±1.0
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column, 7.8×300 mm, mobile phase acetonitrile/50 mM sodium
acetate pH 7.2, 1/1, v/v, flow rate 3 ml/min). The eluate was
collected in 30-s fractions for 15 min, and radioactivity in the
samples was counted. The results were expressed as the percentage
of total plasma radioactivity representing parent tracer.
Scanning
Two rats were scanned simultaneously in each scan session, using a
Siemens/Concorde microPET camera (Focus 220). They were
placed in the camera in transaxial position with their heads and
neck in the field of view. Body temperature of the animals was
maintained with heating mats and electronic temperature control-
lers. Circulation and respiration could be monitored with a BioVet
system (M2M Imaging, Cleveland, OH). First, a transmission scan
of 515 s with a Co-57 point source was obtained for attenuation and
scatter correction of 511 keV photons by tissue. Subsequently, the
first rat was injected through the penile vein with [11C]SA4503 (31
±16 MBq, volume G1 ml). This dose of [11C]SA4503 results in
maximally 5.0 to 7.5 % sigma-1 receptor occupancy throughout the
rat brain, whereas nonspecific binding of the tracer is between 19
and 25 % of total uptake of radioactivity in all the studied brain
regions [28, 29]. The emission scan was started with tracer injection
of the first rat, whereas the second rat was injected a few minutes
later. A list-mode protocol was used with 90-min acquisition time
(analysis performed for the first 74 min from tracer injection). The
list-mode data of the emission scans were split according to
position on the Y-axis and were reframed for each rat indepen-
dently, into a dynamic sequence of 8×30 s, 3×60 s, 2×120 s, 2×
180 s, 3×300 s, 3×600 s, 1×720 s, and 1×960 s frames relative to
the animal’s injection time. The data were reconstructed per time
frame employing an iterative reconstruction algorithm (ordered
subsets expectation maximization, OSEM 2D with Fourier
rebinning, four iterations, and 16 subsets). The final datasets
consisted of 95 slices with a slice thickness of 0.8 mm and an in-
plane image matrix of 128×128 pixels. Voxel size was 0.5×0.5×
0.8 mm. The linear resolution at the center of the field-of-view was
about 1.5 mm. Data sets were fully corrected for decay, random
coincidences, scatter, and attenuation.
Data Analysis
Using Inveon Research Workplace (Siemens), three-dimensional
regions of interest (ROIs) were drawn on an MRI template of the
rat brain [30], both over the whole brain and individual brain
regions (bulbus, cortex, striatum, thalamus, hypothalamus, amyg-
dala, midbrain, pons+medulla, and cerebellum). PET images were
co-registered with this MRI template, and the regions of interest
were transferred from MRI to PET. Time-activity curves (TACs)
were obtained for each of these regions. The results were expressed
as dimensionless standardized uptake values (SUVs): [tissue
activity concentration (MBq/g)×body weight (g)/injected dose
(MBq)], assuming a specific gravity of 1 g/ml for brain tissue and
blood plasma.
Kinetic analysis was performed by fitting a two-tissue compart-
ment model (2-TCM) to the dynamic PET data using metabolite-
corrected arterial plasma radioactivity as input function. Uncorrect-
ed whole blood radioactivity was used to estimate the contribution
of radioactivity in blood to the measured brain radioactivity. The
plasma TAC of each animal was corrected for metabolites using an
exponential function obtained from the average metabolite curve of
the metabolite analysis rats from the same age group. Software
routines for MatLab 7 (The MathWorks, Natick, MA), written by
Antoon T.M. Willemsen (University Medical Center Groningen),
were used for curve fitting. The cerebral blood volume was fixed at
3.6 % [31], and the rate constants K1 (from arterial plasma to
tissue), k2 (from tissue to arterial plasma), k3 (from free to bound
compartment in tissue), and k4 (from bound to free compartment in
tissue) were estimated from the curve fit. Non-displaceable volume
of distribution (VND) was calculated as K1/k2, non-displaceable
binding potential (BPND) as k3/k4, and total distribution volume
(VT) as K1/k2*(1+k3/k4).
In kinetic modeling for brain regions, VND was fixed to the
estimated value for the whole brain of each individual rat.
Additionally, Logan graphical analysis [32] was used to obtain
cerebral distribution volume (VLogan). The Logan fit was started at
20 min, and the parameter for cerebral blood volume was again
fixed at 3.6 % [31]. VLogan of the tracer was estimated from the
curve fit.
Biodistribution
After the scanning period, the animals were terminated under deep
anesthesia by extirpation of the heart. Blood was collected, and
plasma and a cell fraction were obtained from the blood sample by
short centrifugation (10 min at 13,000×g). Several tissues were
excised and weighed. Radioactivity in tissue samples and in a
sample of the injected tracer solution (infusate) was measured using
a gamma counter with automatic decay correction. The results were
expressed both as SUV and as a ratio (SUV tissue/SUV plasma).
Statistics
All results are expressed as mean±SEM. Differences between
groups were examined using t test (for area under the curves and
whole brain 2-TCM parameters) and 2-way ANOVA
(biodistribution, brain and periphery analyzed separately and
regional 2-TCM data), followed by a post hoc Bonferroni test,
where applicable. A P value G0.05 was considered statistically
significant. Correlations were assessed using Pearson correlation
coefficient (r), and considered strong when r2 was at least 0.7.
Results
PET Images
In the brain of young rats (ages 1.5 and 3 months), a
characteristic regional pattern of tracer uptake was seen with
the highest levels in the pons and medulla, followed by the
midbrain, thalamus, and hypothalamus. Lower levels of
radioactivity were noticed in the cortex, striatum, hippocam-
pus, bulbus, amygdala, and cerebellum. In the brains of old
rats (ages 18, 24, and 32 months), regional differences in
tracer uptake were less obvious (Fig. 1).
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Radioactive Metabolites
In plasma of both young and old rats, a time-dependent
formation of two radioactive metabolites was observed.
These metabolites were hydrophilic and eluted at shorter
retention times than the parent compound in reversed-phase
HPLC (Fig. 2). Lipophilic radioactive species were not
detected.
Tracer Kinetics
Tracer uptake in the brain was rapid, a peak at G5 min being
followed by a slow washout (Fig. 3a). The area under the
curve (AUC) for the whole brain was significantly greater at
age 18 to 32 than age 1.5 to 3 months (PG0.01). Metabolism
of [11C]SA4503 was affected by aging. While only 34 % of
plasma radioactivity at 60 min represented intact parent
tracer in young rats, this fraction increased to 54 % in aged
rats (Fig. 3b). The area under the parent fraction curve was
significantly higher (PG0.001) in aged rats.
Tracer clearance was rapid in both the age groups.
Metabolite-corrected time-activity curves (TACs) of plasma
radioactivity were best fitted by a tri-exponential function in
the young and a bi-exponential function in the aged group.
The AUC for aged animals was significantly higher
(PG0.001) than for young rats (Fig. 3c).
Kinetic Analysis
A 2-TCM was fitted to TACs of ROIs drawn around the
whole brain, using metabolite-corrected plasma radioactiv-
ity from arterial blood samples as input function. Repre-
sentative model fits to PET data of a young and an aged rat
are shown in Fig. 4. The fit indicated that tracer VT was
significantly reduced (PG0.001) with aging (Fig. 5a). The
fit parameters suggested that this reduction was due both to
a lower BPND (PG0.01) and a lower K1/k2 (PG0.01) of the
tracer in aged rats (Fig. 5b, c). VT values calculated from a
2-TCM fit or by Logan graphical analysis were strongly
correlated (r2=0.99, PG0.0001), Logan analysis leading to
a slight underestimation of about 5 % (see supplementary
data).
For analysis of tracer uptake in brain regions, a 2-TCM
was fitted to TACs of ROIs derived from the MRI template
in fused PET–MRI images. K1/k2 was fixed to the value
estimated for the whole brain in each individual rat. Fixing
of this ratio improves the fit particularly in small regions and
reduces variability in the fit parameters. Tracer VT in all the
brain regions was significantly lower in the aged group
(Fig. 6a). Tracer binding potential (BPND) was also reduced
by aging in most areas of the brain, but statistical
significance was not reached in the bulbus, cerebral cortex,
and cerebellum (Fig. 6b).
Fig. 1 Images of rat brain (sagittal views, animals
anesthetized with isoflurane). a MRI template. Brain
regions are indicated by the following abbreviations: bu
bulbus olfactorius, ce cerebellum, co cortex, hi hippo-
campus, hy hypothalamus, mb midbrain, p,m pons and
medulla, s striatum, and t thalamus. b MicroPET image of
young rat (age 3 months) superimposed on the MRI
template. c MicroPET image of old rat (age 18 months)
superimposed on this template. Frames from 22 to
74 min were summed (since early frames may contain a
significant contribution of radioactivity in the blood pool),
and a plane was chosen about 1.6 mm from the midline.
Note the high uptake in the pons and medulla of the
young rat whereas the distribution of radioactivity in the
brain of the old rat is more uniform.
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Biodistribution
Biodistribution data for the brain and peripheral organs are
listed in Table 2. At an interval of 90 min after tracer
injection, aged rats showed a significantly lower SUV in the
brain regions other than the cerebellum or cortex, and a
significantly higher SUV in the spleen, submandibular
gland, and urine. However, since plasma levels of radioac-
tivity were different in aged and young rats, tissue-to-plasma
ratios of radioactivity were a better measure of changes in
organ uptake. Tissue-to-plasma ratios in the cerebral cortex
were not significantly affected by aging, but ratios in the
cerebellum and rest of the brain were significantly reduced
in aged rats. Among peripheral tissues, the kidney and liver
demonstrated a significant (PG0.001) reduction of tissue-to-
plasma ratio with aging.
Discussion
The regional distribution of radioactivity which we observed
in the brain of young rats (high in the pons, medulla,
midbrain, and hypothalamus; lower in the caudate–putamen
and cerebellum, see Fig. 1) corresponds to published data for
regional sigma-1 receptor expression in such animals, based
on autoradiography [1], in vitro binding assays [33], and
immunocytochemical techniques. [4] This regional pattern
differs significantly from the distribution of sigma-2 recep-
tors which predominate in other brain areas [2, 34]. The
reduced regional variability of radioactivity in the aged
brains suggests that the impact of aging on [11C]SA4503
uptake is region-specific, some areas showing greater
changes than others, resulting in a more uniform distribution
of radioactivity in the brain of aged rats.
In a previous study with [11C]SA4503, radioactivity in
the rat brain was shown to represent only intact parent
compound [35]. In the present study, we observed both in
the aged and in young rats two hydrophilic radioactive
metabolites in blood plasma which are not expected to enter
the brain (Fig. 2). Lipophilic metabolites were not detected.
Standardized uptake values of radioactivity in the brain,
and areas under the brain and plasma time-activity curves
were significantly higher in the aged animals than in the
young group (Fig. 3a, c). Higher brain and plasma levels in
old animals could be related to the fact that aged rats weigh
more than young ones and SUVs tend to positively correlate
with animal weight. [36] However, the injected PET tracer
was metabolized less rapidly in aged rats, resulting in a
higher fraction of plasma radioactivity representing intact
Fig. 2 Radiochromatograms of rat plasma. Samples were
drawn at different intervals after intravenous injection of
[11C]SA4503: 5 min (a), 10 min (b), 20 min (c), 40 min (d), and
60 min (e). Eluate radioactivity (in CPM) is plotted against
retention time on the HPLC column. The radioactive peak
with 8-min retention time is the parent compound; radioac-
tive species eluting between 4 and 6 min are metabolites.
R
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parent tracer (Fig. 3b). Injected radioactivity was also less
rapidly cleared in old rats (Fig. 3c). The altered shape of the
plasma curve (bi-exponential in aged versus tri-exponential
in young rats), the slower kinetics of radioactivity in plasma,
and the reduced tissue-to-plasma ratios of radioactivity in the
kidney and liver of aged rats (Table 2) suggest that aged
animals have reduced liver and kidney function. Since the
injected probe was less rapidly metabolized and cleared,
more tracer remained in plasma and was available for
delivery to the brain.
Tracer levels in the circulation should be taken into
account when groups are compared. Distribution volumes or
binding potentials of the radioligand estimated by graphical
analysis of PET data or by tracer-kinetic modeling can be
used for this purpose [37]. Tissue-to-plasma ratios of
radioactivity determined at a long interval after tracer
injection could also be used as an estimate of receptor
binding.
Tracer distribution volume and binding potential in the
whole brain, calculated from a 2-tissue compartment model
fit (Fig. 4), were reduced after aging (Fig. 5). When tracer
binding potential was calculated for individual brain regions,
some areas of the brain appeared to be little affected whereas
other areas showed significant reductions. The greatest
decreases were noted in the thalamus, hypothalamus,
midbrain, pons, and medulla (Fig. 6). The fit data indicate
that the more uniform distribution of radioactivity which we
observed in the aged brain (Fig. 1) is due to substantial age-
Fig. 3 Tracer kinetics in brain and plasma of young and aged rats: whole brain TACs and AUCs (a), fraction of plasma
radioactivity representing intact parent tracer as a function of time after injection and area under this curve (b), and metabolite-
corrected TACs and AUCs in plasma (c). All data are plotted as mean±SEM. ** indicates PG0.01 and *** PG0.001.
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related losses of tracer binding in some areas (particularly
pons/brainstem, medulla, midbrain, thalamus, and hypothal-
amus) whereas losses in other areas (particularly cortex) are
smaller and statistically non-significant. Tissue-to-plasma
ratios of radioactivity determined 90 min after tracer
injection indicated that uptake in the cerebral cortex was
not significantly affected by aging whereas uptake in the
cerebellum and the rest of the brain was significantly
reduced (Table 2). Thus, our data support a loss or down-
regulation of sigma-1 receptors in most brain areas with
aging, particularly in the pons, medulla, midbrain, thalamus,
and hypothalamus, whereas sigma-1 receptors in the cerebral
cortex appear to be rather well preserved.
Besides decreases of distribution volume and binding
potential, the 2-TCM fit indicated a decrease of K1/k2, which
suggests a decrease of tracer entry into the brain. In an
American study on Sprague–Dawley rats (which are closely
related to our own Wistar Hannover strain), a 25–33 %
decline of regional cerebrovascular permeability surface area
product was detected when animals aged from 6 to
24 months [38]. This decline corresponds closely to our
observed decrease of K1/k2.
The strong correlation which we observed between
estimations of VT by 2-TCM fit and Logan plot suggests
that Logan graphical analysis can be used as a robust method
Fig. 4 Kinetics of 11C]SA4503 in rat brain and the corre-
sponding 2-TCM fits in young (a) and aged animal (b).
Fig. 5 Data fromawhole brain 2-TCM fit in young and aged rats.
Plotted are VT (a), BPND (b), and K1/k2 (c). **PG0.01, ***PG0.001.
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to quantify [11C]SA4503 uptake in the rodent brain, as we
had noted previously [28, 29, 39].
Although our study is the first report of sigma-1 receptor
imaging in rats of different ages, the impact of aging on
sigma receptor expression in the rodent brain has been
examined previously using in vitro assays. Unfortunately,
most previous studies employed non-subtype-selective sig-
ma ligands ([3H]-1,3-ditolylguanidine, [3H]haloperidol), so
that measured receptor densities corresponded to the sum of
the sigma-1 and sigma-2 receptor populations and cannot be
compared to the present results with [11C]SA4503 [20, 21,
24]. A decline of sigma-1 receptor expression between birth
and adult age (i.e., 50 days) was detected in the whole brain
homogenates of Sprague–Dawley rats [22]. Using
[3H]SA4503 as radioligand, a 4.5-fold increase of sigma-1
receptor density (Bmax) was observed in the whole brain of
Fisher-344 rats between ages 1.5 and 24 months, but since
the affinity of the receptor for the radioligand declined 3.8-
Fig. 6 Data from 2-TCM fits in brain regions of young and aged rats. Plotted are VT (a) and BPND (b). *PG0.05, **PG0.01,
***PG0.001, ns not significant.
Table 2. Biodistribution of [11C]SA4503 (90 min after injection)
SUV T/P ratio
Tissue Young (n=16) Aged (n=13) P value Young (n=16) Aged (n=13) P value
Cerebellum 1.31±0.09 1.33±0.10 ns 12.70±1.37 8.23±1.00 G0.05
Cerebral cortex 1.30±0.08 1.56±0.11 ns 12.43±1.06 9.66±1.11 ns
Rest brain 1.75±0.10 1.36±0.09 G0.05 16.79±1.52 8.45±0.98 G0.001
Adipose tissue 0.47±0.06 0.28±0.06 ns 4.40±0.56 1.66±0.36 ns
Bladder 1.30±0.20 2.34±0.73 ns 13.04±2.63 14.67±5.14 ns
Bone 0.46±0.05 0.43±0.05 ns 4.19±0.49 2.58±0.31 ns
Bone marrow 2.29±0.91 3.15±0.73 ns 20.97±8.38 17.67±3.57 ns
Heart 0.36±0.03 0.65±0.04 ns 3.51±0.44 3.92±0.39 ns
Large intestine 1.91±0.10 2.20±0.16 ns 18.17±1.53 13.51±1.55 ns
Small intestine 2.29±0.22 3.18±0.26 ns 22.08±2.96 19.49±2.26 ns
Kidney 4.40±0.23 3.50±0.21 ns 42.00±3.47 21.30±1.89 G0.001
Liver 9.30±0.39 10.78±0.47 ns 87.37±5.45 65.30±5.37 G0.001
Lung 2.07±0.11 2.24±0.16 ns 19.69±1.69 13.61±1.38 ns
Muscle 0.17±0.02 0.35±0.06 ns 1.76±0.27 2.13±0.43 ns
Pancreas 5.18±0.51 5.63±0.59 ns 48.46±5.86 34.75±4.99 ns
Plasma 0.11±0.01 0.17±0.01 ns 1.00 1.00 ns
Red blood cells 0.06±0.01 0.09±0.01 ns 0.63±0.07 0.50±0.06 ns
Spleen 2.47±0.17 4.45±0.30 G0.01 23.52±2.11 27.28±2.81 ns
Submandibular gland 3.29±0.25 5.98±0.59 G0.001 30.82±2.72 36.20±4.58 ns
Urine 1.58±0.28 3.32±1.22 G0.05 14.51±2.67 21.33±8.50 ns
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fold during the same period, the binding potential (Bmax/Kd)
was only slightly increased [23]. Using [3H]-(+)-pentazocine
in Fisher-344 rats, smaller (1.5-fold) increases of sigma-1
receptor density were noticed with corresponding (1.4-fold)
decreases of ligand affinity and no significant change of
binding potential [23]. Results for individual brain regions
were not reported.
Reductions of sigma-1 receptor binding in the midbrain,
pons, and medulla could be related to motor problems in aged
animals, since sigma-1 receptors in these brain areas are
primarily located on motor neurons and sigma-1 receptor
knockout results in a reduced ability of mice to remain on the
rotarod [40]. Pharmacological studies in isolated tissue have
also suggested that brainstem sigma-1 receptors are involved in
the regulation of motor responses [41]. Reduced sigma-1
receptor binding in the hypothalamus may be associated with
impaired responses of aged animals to stress, since hypotha-
lamic sigma-1 receptors are required for stimulation of brain-
derived neurotrophic factor (BDNF) expression and the
hypothalamus plays an important role in regulating the activity
of the hypothalamus-pituitary-adrenal (HPA) axis [42].
Conclusions
Our microPET study provides evidence for changes of
sigma-1 receptor binding in the aging rat brain which are
regionally different. Binding potential of the agonist tracer
11C]SA4503 was reduced in the (hypo) thalamus, midbrain,
pons, and medulla, but rather well preserved in the cortex.
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